Conference abstract · 12 Mar 2018
Conference abstractPublished 27 Jul 2015
RNA Editing Alters MicroRNA Targeting in Human Breast Cancer
University of South Alabama, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
RNA editing by RNA specific adenosine deaminase (ADAR) is increasingly being found to alter microRNA (miR) regulations. Editing of miR transcripts can affect their processing as well as what mRNAs they target. Further, editing of target mRNAs can also affect their complementarily to miRs. Notably, ADAR editing is often increased in malignancy with the effect of these RNA changes largely unclear. In addition, reports have also identified many miRs to be differentially expressed in cancer though the majority of their targets are also undefined. Here we propose that modulating the targets of miRs via mRNA editing can play a direct role in the pathology of many carcinomas. In order to more accurately characterize the relationship between these two regulatory processes this study examined RNA editing events within mRNAs sequences of two breast cancer cell lines (MCF-7 and MDA-MB-231) and determined whether or not these edits modulate miR associations. Computational analyses of RNA-Seq data from the two cell lines identified over 250,000 edit sites within mRNAs, many of which were located in 3’ UTR regions. When these locations were screened against the list of currently annotated miRs we discovered that editing caused a subset (~5%) to have significant alterations to mRNA complementarity. One miR in particular, miR-140-3p has been shown to be abhorrently expressed in many breast cancers. Interestingly, we found that mRNA editing made this specific miR able to target the apoptosis inducing gene DFFA in MCF-7 but not in MDA-MB-231 cells. As these two cell lines are known to have distinct characteristics in terms of morphology, invasiveness and physiological responses, it is feasible that RNA editing could contribute to the phenotypic differences observed between the two cell lines and help explain why an increased incidence of ADAR activity is detected in a number of malignancies. Broadly, these results suggest that the creation of miR targets may be an underappreciated function of ADAR and may help further elucidate the role of RNA editing in tumor pathogenicity.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2 Jul 2012
Identification and characterization of a novel role for RNA helicase DP103: The key �missing player� and therapeutic target for NFkB-induced metastasis in human breast cancer
Conference abstract · 20 Oct 2014
Targeting WNT1-inducible signaling pathway protein 2 (WISP2) alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression
Conference abstract · 2 Sep 2016
MicroRNA: A small non-coding RNA, an efficient biomarker for prostate cancer
Conference abstract · 30 May 2022
Clinical Relevance of RNA Editing to Early Detection of Cancer in Human
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGenetics & Molecular Biology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Glen M Borchert”
